Journal Article Epublish 10 citations
PubMed: 34854280 DOI: 10.3324/haematol.2021.280139
Dissociated humoral and cellular immune responses after a three-dose schema of BNT162b2 vaccine in patients receiving anti-CD20 monoclonal antibody maintenance treatment for B-cell lymphomas.
Haematologica 107(3):755-758
Authors: Sophie Candon, Veronique Lemee, Emilie Leveque, Pascaline Etancelin, Cedric Paquin, Marion Carette, Nathalie Contentin, Victor Bobee, Mustafa Alani, Nathalie Cardinael, Stephane Lepretre, Vincent Camus, Florian Bouclet, Edwige Boulet, Anne-Lise Menard, Helene Lanic, Aspasia Stamatoullas, Emilie Lemasle, Louis-Ferdinand Pepin, Doriane Richard, Sydney Dubois, Herve Tilly, Alain Dalleac, Jean-Christophe Plantier, Manuel Etienne, Fabrice Jardin
Affiliations
- Laboratory of Immunology and Biotherapies, Rouen University Hospital; INSERM U1234, University of Rouen Normandy, Rouen.
- Normandie Univ, UNIROUEN, UNICAEN, GRAM 2.0, Rouen University Hospital, Department of virology, F-76000 Rouen.
- Unit of Clinical Research, Centre Henri Becquerel, 76038, Rouen.
- Department of Biopathology, Centre Henri Becquerel, 76038, Rouen.
- Laboratory of Immunology and Biotherapies, Rouen University Hospital.
- Department of Clinical Hematology, Centre Henri Becquerel, 76038, Rouen.
- Laboratory of Hematology, Rouen University Hospital.
- Cliniques universitaires UCL de Mont Godinne, 5530, Namur, Belgique.
- Department of Clinical Hematology, Centre Henri Becquerel, 76038, Rouen, France; INSERM U1245, University of Rouen Normandy, Rouen.
- Normandie Univ, UNIROUEN, UNICAEN, GRAM 2.0, Rouen University Hospital, Department of infectious diseases, F-76000 Rouen.
- Department of Clinical Hematology, Centre Henri Becquerel, 76038, Rouen, France; INSERM U1245, University of Rouen Normandy, Rouen.
MeSH
Hematology, Immunity, Lymphoma, B-Cell, Vaccines, Cells, Therapeutics, Maintenance, Antibodies, Monoclonal, B-Lymphocytes
Cited by
- Rituximab-treated patients with lymphoma develop strong CD8 T-cell responses following COVID-19 vaccination. Br J Haematol, 2022
- Back to the Future: Immune Protection or Enhancement of Future Coronaviruses. Microorganisms, 2024
- Can B cell-deficient patients rely on COVID-19 vaccine-induced T-cell immunity? Br J Haematol, 2022
- Anti-SARS-CoV-2 cellular response after 2 and 3 doses of BNT162b2 mRNA vaccine in lymphoma patients receiving anti-CD20 antibodies. Vaccine, 2023
- Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis. Blood Cancer J, 2022
- Bendamustine impairs humoral but not cellular immunity to SARS-CoV-2 vaccination in rituximab-treated B-cell lymphoma-affected patients. Front Immunol, 2023